News by region

  • VYNE and Yarrow agree merger to advance YB-101

    VYNE and Yarrow agreed a merger to form Yarrow Bioscience and advance YB-101, a TSH receptor antibody for Graves’ and thyroid eye disease. The all-stock deal will see the combined company operate as Yarrow Bioscience and list on Nasdaq under YARW, subject to approvals. Closing is targeted for the second quarter of 2026. Pre-closing financings [...]

  • OpenAI considers move into consumer health apps

    OpenAI is reportedly exploring a move into consumer health tools, including a personal health assistant or health data aggregator. Sources close to the company told Business Insider that the AI giant is weighing several opportunities as it pushes into healthcare, a sector where tech giants including Google, Amazon and Microsoft have struggled to gain traction. [...]

  • Infant nutrition in the age of AI search: What every brand needs to know

    By EatMoreFruit Communications The way parents discover, evaluate, and trust infant nutrition information is evolving faster than ever. Traditional Google search once served primarily as a link-finder, delivering ranked webpages based on SEO keywords. Today, AI-driven search tools such as Google’s AI Overviews to Perplexity, ChatGPT, and other large language model (LLM) powered assistants, now [...]

  • French preventive healthcare startup Lucis secures €7.2m

    Lucis has announced it has closed a US$8.5 million seed funding round led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures. The funding will enable the startup to accelerate its rollout in France, the UK, Ireland and Portugal, as well as in new markets, expand its [...]

  • AI-driven digital tool delivers sustained blood pressure reductions, study finds

    A large real-world study has found that an AI-powered digital tool developed by Megi Health can significantly reduce blood pressure over time while maintaining high long-term patient engagement -  a combination that has remained a major challenge in hypertension care. The peer-reviewed research, published in JMIR mHealth and uHealth, analysed real-world data from more than [...]

  • SRx Health in EMJX acquisition, names new chief executive

    SRx Health agreed the acquisition of EMJX, pivoting from healthcare to a digital asset platform; Eric M. Jackson will be chief executive and chair on closing. SRx Health Solutions said it has a definitive agreement to acquire EMJ Crypto Technologies (EMJX). The deal marks a shift from healthcare to building a digital asset treasury platform, [...]

  • Acceptable data use vs exploitation when cancer patients receive ‘free’ digital health tools

    By Wolfgang Hackl, CEO, OncoGenomX Inc., Allschwil, Switzerland In precision oncology, nothing is more sensitive - or more valuable - than patient data. Genomic profiles, longitudinal symptom logs, treatment responses, tumour evolution patterns, imaging signatures, real-world toxicity data, and behavioural markers power a new generation of AI-driven oncology tools. They promise earlier detection, better prognostic [...]

  • Why cyber security leadership is now a patient safety issue

    Odgers’ Chris Hamilton and Mike Drew explain why cyber security leadership is now paramount for most healthcare providers In hospitals across the world, cyberattacks have moved from disrupting systems to endangering lives. When an attack locks clinicians out of patient files or disables connected medical devices, care can stall in critical moments. The line between [...]

  • Opinion: How AI will transform patient journey management in 2026

    By Kyle Lunn, managing director, health, ClearCourse AI is rapidly changing the way patients want to interact with healthcare professionals and is moving past proof-of-concept into routine clinical and administrative use. In 2026, clinics will increasingly experiment with AI Agents and conversational AI, like chatbots and assistants, as ‘digital front doors’ for patients. [...]

  • Scientists to ‘spy’ on cancer- immune cell interactions using quantum tech

    An innovative quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a £2 million Future Leaders Fellowship. The four-year fellowship, funded by UK Research and Innovation (UKRI), focuses on a critical problem: immune cells often fail when they encounter cancer tissue because the tumour environment [...]